Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-625-3
CAS number: 68131-72-6
The substance is a UVCB. It is a pale yellow liquid and the molecular weight is >119.96 - < 521.02 g/mol. The low vapour pressure value (1.0 Pa at 25°C) and predicted negative explosive and oxidising properties shows that the substance is non volatile therefore inhalation is not a significant route of exposure. The substance has a low log octanol/water partitioncoefficient value (Log10Pow -4.23 and high water solubility (miscible at 20°C). The available acute dermal and repeated dose reproductive screening studies showed limited evidence of absorption, metabolism and excretion.
The test item was non-mutagenic in bacteria and non-clastogenic in mammalian cells in vitro, however it was mutagenic in mammalian (CHO) cells in vitro in the absence of an auxiliary metabolising system.
The test item is not a skin sensitizer however it is considered a mild irritant.
Although the test item is lipophobic in nature the high water solubility (miscible at 20°C ) and small molecular size of the substance could allow absorption through
passive diffusion. This would suggest that the gastro-intestinal tract provides a route of absorption, following oral administration, before entering the circulatory system via the blood.
Limited absorption may also take place via the skin due to small molecular size and water solubility. Although the substance is not a skin sensitizer there is evidence of mild dermal irritation (from dermal irritation and skin sensitization studies). Therefore damage to the skin surface may allow for increased penetration of the substance through the skin.
The low vapour pressure value (1.0 Pa at 25°C) shows that the substance is not available as a vapour therefore inhalation is not a significant route of exposure.
Once absorbed, the substance may be distributed in serum due to the water solubility and may therefore be distributed systemically. The lack of evidence to suggest the test item is a sensitizer suggests that it does not bind to circulatory proteins. The high water solubility would also suggest that the test item does not accumulate in body fat.
The results of the repeated dose reproductive screening study did not show evidence to indicate any test item influenced hepatic metabolism. The results of the reverse mutation assay showed no evidence that genotoxicity is either enhanced or diminished in the presence of the S9 metabolising system. On the other hand in a mutagenicity study using mammalian (CHO) cells in vitro, the elimination of the mutagenic response by the addition of a rat S9 metabolising system suggests that the test substance may undergo hepatic metabolism in the intact animal.
There is no evidence to indicate the route of excretion but high water-soluble products are not favorable for biliary excretion and therefore urinary excretion may well be a significant route for this material. Any test item that is not absorbed will be excreted in the faeces.
The available information suggests that the substance is readily available via the oral route; however absorption via the skin is also possible. This is supported by the physicochemical properties of the substance. Once absorbed, the substance would result in distribution in the serum. Urinary excretion is considered to be the significant route for the substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again